3.4.7. Mild Asymptomatic Cancer-Therapy-Related Cardiac Dysfunction
myocardial damage
In summary, mild asymptomatic CTRCD, defined by the 2022 ESC Cardio-Oncology Guidelines, was detected in 29 patients (60.4%). Of these, 10 were in the ivabradine group and 19 in the control group (The alteration of cardiac biomarkers is presented in According to the recent recommendations, patients who developed mild CTRCD were prescribed cardioprotective treatment with 2–4 mg of perindopril and monitored every 4 weeks until test results normalized.All myocardial damage markers are presented in 